IDO1 anticorps (C-Term)
-
- Antigène Voir toutes IDO1 Anticorps
- IDO1 (Indoleamine 2,3-Dioxygenase 1 (IDO1))
-
Épitope
- C-Term
-
Reactivité
- Humain
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp IDO1 est non-conjugé
-
Application
- Western Blotting (WB)
- Specificité
- Human IDO1 / IDO
- Homologie
- Percent identity by BLAST analysis:
- Purification
- Immunoaffinity purified
- Immunogène
-
Synthetic peptide from C-Terminus of human IDO1 (P14902, NP_002155). Percent identity by BLAST analysis: Human, Chimpanzee, Gorilla, Orangutan, Gibbon (100%), Rabbit (92%).
Type of Immunogen: Synthetic peptide - Top Product
- Discover our top product IDO1 Anticorps primaire
-
-
- Indications d'application
- Optimal working dilution should be determined by the investigator.
- Commentaires
-
Target Species of Antibody: Human
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Distilled water
- Concentration
- Lot specific
- Buffer
- Lyophilized from PBS with 2 % sucrose
- Conseil sur la manipulation
- Avoid repeat freeze-thaw cycles.
- Stock
- 4 °C,-20 °C
- Stockage commentaire
-
Long term: -20°C, the use of 50% glycerol is recommended if storing aliquots in -20°C for long term use (up to 1 year)
Short term (less than 1 week): 4°C. Avoid freeze-thaw cycles.
-
- Antigène
- IDO1 (Indoleamine 2,3-Dioxygenase 1 (IDO1))
- Autre désignation
- IDO1 / IDO (IDO1 Produits)
- Synonymes
- anticorps INDO, anticorps ido, anticorps indo, anticorps IDO, anticorps cd107b, anticorps IDO1, anticorps IDO-1, anticorps Ido, anticorps Indo, anticorps indoleamine 2,3-dioxygenase 1, anticorps indoleamine 2,3-dioxygenase 1 L homeolog, anticorps indoleamine 2,3-dioxygenase 1-like, anticorps IDO1, anticorps ido1.L, anticorps ido1, anticorps Ido1, anticorps LOC100050681
- Sujet
-
Name/Gene ID: IDO1
Synonyms: IDO1, IDO, Indole 2,3-dioxygenase, Indolamine 2,3 dioxygenase, IDO-1, INDO, Indoleamine 2,3-dioxygenase, Indoleamine 2,3-dioxygenase 1 - ID gène
- 3620
- NCBI Accession
- NP_002155
- UniProt
- P14902
- Pathways
- Activated T Cell Proliferation
-